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Capillary electrophoresis/electrospray ionization using an ion trap storage/reflectron time-of-flight mass
spectrometer detector (CE/ESI-IT/reTOF) is used to provide a rapid and sensitive method for analyzing
structural variants in the hemoglobin (Hb) â-chain. The Hb α- and â-chains are separated and the â-chain is
digested by trypsin. The digest is analyzed by CE/ESI-IT/reTOF where a comparison of the total ion
electrophorograms and mass spectra of the mutant and normal hemoglobins (Hbs) can detect the presence of
a mutation site. In addition, collision-induced dissociation in the vacuum interface – skimmer region can be
used to pinpoint the identity of such a site. The unique capability of the CE/ESI-IT/reTOF system for
accurately detecting fast separations with narrow peaks that may be under 1 s full width at half maximum is
demonstrated. The speed of this system is essential for resolution of the large number of peaks that are
separated in a short time duration using CE separations. © 1997 by John Wiley & Sons, Ltd.
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Since the discovery of its first variant in 1956,1
hemoglobin (Hb) has been an important subject for
biological research and clinical practice. The presence
of abnormal hemoglobins can cause severe diseases
directly related to the structure of the Hb. Most of the
more than 700 structural variants2 known to date are
single amino acid substitutions in either the α- or
â-chains, although chain elongation, deletion and other
mutations may be found. The conventional detection of
hemoglobinopathies relies on electrophoresis3 and iso-
electrofocusing,4 which are labor intensive and time
consuming, often requiring several days to complete.
More recently, reversed-phase high-performance
liquid chromatography (RP-HPLC) of either Hb or its
tryptic digests has been used to identify Hb variants
when the analysis time is typically under 1 h.5 The
analysis of Hb was significantly improved by Shelton et
al.6 who used large-pore C4 columns together with
simplified acetonitrile–water–trifluoroacetic acid (TFA)
gradients to separate and identify the whole globin
chains from normal and variant hemoglobins. A more
definitive method used tryptic digestion of Hb with
HPLC separation for identification of variant globins
based upon a comparison of the tryptic fragments
produced.7,8 In the tryptic fragments of Hb there are 29
digestion peaks for normal adult hemoglobin (HbA),
four of which, αT12, αT13, âT10, and âT12 are
insoluble and precipitate out during the digestion
preparation; two other single amino acid products, αT8
and âT8, are not detected with a UV absorbance
detector at 200 nm.9 Substitution of amino acids
between normal Hb and one of its variants results in a
change of the position and number of the fragments.
The HPLC method provides an important advantage
over conventional electrophoresis in terms of the time
of analysis. However, HPLC is unable to efficiently
resolve all peptides in Hb tryptic digests, and over-
lapping and unresolved peaks may make identification
difficult. Nevertheless, much work has been done
developing HPLC methods for the characterization of
clinical Hb mutations.7
The recent development of capillary electrophoresis
(CE)10,11 has provided a complementary method to
HPLC and gel electrophoresis. The high sensitivity and
superior resolving power of CE has led to its use in
solving important problems in the biological and
biomedical fields. Perrett et al.9 studied the tryptic
mapping of some common and rare Hb variants using
CE separation with UV detection. They readily
observed the abnormal peptide fragments which could
be identified by comparison between the normal and
abnormal tryptic map profiles. Various other research-
ers, including Casragbola12 and Ong,13 have used CE
for the separation of globin chains in a rapid identifica-
tion of variant hemoglobins where separations could be
performed within 10 min.
In order to unambiguously prove the presence of a
hemoglobin mutation and to identify the variant sites,
mass spectrometry has been successfully combined to
separation techniques such as HPLC or CE, either off-
line or on-line. The use of mass spectrometry in Hb
analysis by Matsuo et al.14 incorporated field desorption
and fast-atom bombardment mass spectrometry (FAB-
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MS) in the analysis of the tryptic digests of α-, â-, and
δ-chains. In subsequent work, Ferranti and co-
workers15 used CE separation of globin chains and
tryptic digests with detection by FAB-MS to character-
ize hemoglobinopathies. In this work, the fractions
from CE were collected and sequentially determined
off-line by mass spectrometry. The obvious disadvan-
tage of this method is that it is extremely difficult to
collect the fast-eluting electrophoretic peaks, and the
small sample amount was not sufficient for FAB mass
analysis for some fragments. More recently, several
groups16–19 have coupled microbore HPLC on-line with
electrospray ionization mass spectrometry (ESI-MS) to
identify various Hb mutations. The use of microbore
columns improved the analysis time compared with
previous HPLC work but is still considerably longer
than the time-frame that can be achieved by using a CE
separation. In addition, much improved resolution
could be achieved using CE as compared to HPLC.
Other mass spectrometric methods have also been used
for the analysis of Hb variants. Biemann’s group20 used
matrix-assisted laser desorption/ionization time-of-
flight mass spectrometry (MALDI-TOFMS) without
separation to analyze the proteolytic digests of the
normal and cross-linked Hb â-chains. Other groups21–25
have used a mass spectrometer without separation,
directly applying tandem mass spectrometry (MS/MS)
and collision-induced dissociation (CID) on the entire
Hb protein or separated α- and â-chains, to identify the
variation sites in a series of abnormal hemoglobins. The
mass analysis provides unambiguous identification for
most of the fragments and confirms the variant sites
inside the specific chains. However, the mass fragments
of the entire multiply-charged Hb molecule result in
sequence information for ~ 29% of the molecule21 and
it can only be used to confirm certain common
mutations that lie within the well-known tryptic map-
ping regions.17 In addition, the resulting MS/MS or CID
spectrum is complicated and it requires extensive
calculation and comparison for accurate analysis, espe-
cially where mutations may result in a shift of only a
couple of mass units.
This work reports on the analysis of globin chain
digests in several variant hemoglobins using on-line
CE/MS with amine-coated fused-silica capillaries
where the CE anodic end was directly applied as the
microelectrospray needle. The results demonstrate that
using the CE capability for fast separation, combined
with mass analysis, a rapid and sensitive method could
be developed in the screening and detection of abnor-
mal Hbs. Since the electrophoretic peaks from CE are
as narrow as 1 s, a fast mass detector that can acquire
the data with sufficient speed is required in order to
maintain the quality of the total-ion electrophorogram
(TIE) peaks and the high CE resolution. The system
utilized in these experiments is an ion trap storage/
reflectron time-of-flight (IT/reTOF) mass spectrometer
that is capable of acquiring a single mass spectrum at a
speed of greater than 10 Hz,26 thus maintaining the
separation efficiency of the CE. This is an important
advantage in preserving high resolution separations
coupled to mass analysis. In addition, the storage
properties of the ion trap and the nonscanning nature
of the IT/reTOF system result in a very high duty cycle
even at the data acquisition rate required in these
experiments. This method provides improved sensitivity
in detection over a broad mass range for detection of
low intensity signals in these CE separations.
EXPERIMENTAL
Preparation of Hb
The Hb protein was prepared in a manner similar to the
method reported by Perrett et al.9 Hemolysates were
prepared from blood by washing erythrocytes three
times with an equal volume of normal saline buffer.
Washed red cell samples (0.5 mL) were centrifuged to
remove any additional impurities and the supernatant
liquid was aspirated. The cells were lysed by diluting
with 2.5 mL distilled water, and centrifuged at 8000 g
for 15 min to isolate the cell membrane and other solid
materials. The supernatant liquid was then added drop-
by-drop into a cold acid acetone (conc. 2%) solution to
precipitate the globin and to be dehemed; the tube was
shaken vigorously during this procedure. After centri-
fugation at 3000 g for 10 min, the supernatant liquid
was removed and acetone was added to wash the
precipitate. This procedure was repeated twice before
the proteins were vacuum dried. The prepared globin
was redissolved in deionized water for further use.
Separation
The separation of Hb chains was performed with an
HPLC system (Model Rabbit-HP, Rainin Instruments
Co. Inc., Emeryville, CA, USA) using a C18
4.6 mm × 30 cm column. The Hb chains were separated
using a gradient from 45% to 55% acetonitrile contain-
ing 0.1% trifluoroacetic acid (TFA). Detection was
performed using a UV absorption detector at 214 nm
and the eluent was further identified by mass analysis.
The sample was vacuum dried and tryptic digestion was
applied to the α- and â-chains separately. Subsequently,
the â-chains of both the normal and variant Hbs were
digested by TPCK-treated trypsin with a substrate to
enzyme ratio (50:1) in NH4HCO3 solution at pH 8.4 for
24 hours at 37 °C. The digests were then vacuum dried
and reconstituted in the CE buffer.
Capillary electrophoresis was performed on a home-
built apparatus using a ± 30 kV high voltage power
supply (Model CZE 1000R, Spellman High Voltage
Electronics Corp., Plainview, NY, USA). In order to
minimize the adsorption of peptides to the capillary
wall, the inner wall of the capillaries was coated by a
method similar to that described by Moseley and co-
workers27 with minor modification. A 60 cm capillary
(105 µm o.d., 40 µm i.d.) was rinsed with 1 M NaOH
solution for 4 h, followed by flushing with H2O for
10 min, 5 M HCl solution for 30 min, and H2O for
another 10 min. The capillary was then dried with pure
nitrogen gas at 90 °C overnight. Subsequently, it was
washed with toluene for 30 min and 2.5% (v/v) 3-ami-
nopropyl-trimethoxy silane (APS) coating solution
(toluene) was pumped through the capillary for 12 h.
The capillary was conditioned with the CE buffer for
4 h prior to use. The buffer used in all of the
experiments was 10 mM ammonium acetate with
slightly varying pH, depending on the different samples
separated. All of the CE separations were performed in
the negative-ion mode with an electrical field strength
of ~ –300 V/cm. A variable wavelength UV detector
(Model SC100, Thermo Separation Products, Fremont,
CA, USA) with the wavelength set at 198 nm was
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initially used to monitor the CE separation process. The
samples were injected using the electrokinetic method
which loads approximately 50–100 fmol protein digests
for each run. The injection, separation, and data
acquisition procedures were remotely controlled by a
personal computer (Model P5-66, Gateway 2000 Inc.,
N. Sioux City, SD, USA), where an ADC-16 analog
board was applied to collect the UV signal at a
frequency of 7 Hz where custom software controlled all
procedures.
On-line sheathless CE/MS
The mass spectrometer used in these experiments was
an IT/reTOF system as described in previous work.28,29
It consists of a reflectron TOF mass analyzer (Model
D1450) coupled to a front end quadrupole ion trap
storage device (Model C-1251, R. M. Jordan Co., Grass
Valley, CA, USA). The pressures inside the ion trap
main chamber and the TOF tube are 1 × 10–5 Torr and
2 × 10–7 Torr, respectively. In the IT/reTOF, ions are
stored for a specific period of time in the ion trap with
a preset RF voltage of 1100 V and a frequency of
1.1 MHz on the ring electrode. A helium buffer gas is
added to the trap at a pressure of ~ 10–3 Torr in order
to enhance trapping of ESI-produced externally-
injected ions. Subsequently, a DC pulse voltage of
400 V is applied to the endcap of the trap to eject ions
into the reTOF for mass analysis. Ions were detected by
a 25 mm triple microchannel plate detector (Model
C-2501, R. M. Jordan Co.).
The sheathless microelectrospray interface was con-
structed by using the capillary end as the electrospray
needle as reported previously.30 Briefly, the capillary tip
was etched from a dimension of 105 µm o.d. to a fine
diameter with concentrated hydrofluoric acid after 1 cm
of polyimide coating had been removed. The outer
surface of this tip was silver coated by using the
electroless plating process,31 which includes degreasing
in CH2Cl2, surface sensitization in a sensitizer solution,
and finally insertion into the electro-plating solution of
silver nitrate. This silver coating provided electric
contact for both electrospray and capillary electro-
phoresis, by inserting the capillary tip into a 2 cm s.s.
tube (125 µm i.d., 250 µm o.d.) connected to the
electrospray power supply. One end of the capillary was
set at around –13 kV, while the needle was at an
electrospray voltage of ~ 4 kV so that the total CE
separation voltage was around –17 kV. The needle
formed a stable electrospray plume with a resulting
mass signal, provided the outer surface was period-
ically recoated with silver.
The mass signals were collected using a 250 MHz
transient recorder (Model 9846, Precision Instruments
Inc., Knoxville, TN, USA) embedded in a P5-66
personal computer, where the data processing was also
conducted. This data acquisition system could acquire
data at 25 Hz for a CE separation for over half an hour,
using software developed in our laboratory.26 A time-
of-flight expansion range of 0 to 150 µs, which corre-
sponds to an m/z range of 0–1500, was generally used as
the mass acquisition period. Mass calibration was
performed using three standard peptides, viz. bradyki-
nin, angiotensin I and Leu-Enk-Arg, according to the
following equation, (m/z)1/2 = aT + b, where T is the
flight time.
CID in the vacuum interface – skimmer region
In order to detect the mutation site inside the specific
fragment, CID of the CE-separated fragment was
performed by raising the focusing lens voltage from
100 V to 150 V–200 V. When the target digest fragment
was about to elute from the capillary, the focusing lens
voltage was rapidly increased in this way so that
dissociation occurred in the region between the focus-
ing lens and the skimmer.
Mass analysis of HPLC-separated globin chains
The confirmation of the mass values for the collected
HPLC-separated Hb chains was performed by
MALDI-MS using a linear time-of-flight mass spec-
trometer (R. M. Jordan Co.). The spectra were acquired
using 355 nm radiation from a DCR-11 Nd:YAG laser
system (Spectraphysics, Mountain View, CA, USA).
The matrix used was α-cyano-4-hydroxycinnamic acid,
which was prepared in acetonitrile, deionized water and
TFA (50:49:1). The mixture of protein and matrix (1:1)
was placed on the probe tip and allowed to dry, before
being subjected to mass analysis.
Materials and chemicals
Ammonium bicarbonate, TFA, ammonium acetate,
acetonitrile, toluene, acetone, sodium hydroxide,
hydrochloric acid, silver nitrate, formaldehyde, ammo-
nium hydroxide, 3-aminopropyl-trimethoxy silane,
angiotensin I, bradykinin, and Leu-Enk-Arg were
purchased from Sigma (St. Louis, MO, USA). TPCK-
treated trypsin was purchased from Promega (Madison,
WI, USA). These materials were used without further
purification. The water was filtered and deionized prior
to use by a Milli-Q water purification system (Millipore
Corp., Bedford, MA, USA). HbA was obtained from
Sigma Co., while sickle cell anemia (HbS) and HbE
samples were obtained as a gift from the World
Figure 1. HPLC separation of HbA globin chains.
Conditions: C18 column (30 cm, 4.6 mm i.d.), Gradient:
45–55% acetonitrile containing 0.1% TFA in 60 min.
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Laboratory (Ann Arbor, MI, USA). Fused-silica capil-
laries were purchased from Polymicro Technologies
(Phoenix, AZ, USA).
RESULTS AND DISCUSSIONS
The goal of this work is to pinpoint mutations in variant
hemoglobins. In order to simplify this task we have
chosen to separate the α- and â-chains of Hb before
digestion so that the mutation can be initially identified
as being in one or the other of the protein chains. The
tryptic digestion of the α- and â-chains of Hb together
provides 29 peaks, so that it is preferable to separate
the proteins before digestion to simplify the assignment
of the mutation. This becomes especially important in
many variant Hbs where the mutation may result in a
mass difference of only 1 Da or where minor chains,
such as γ- and δ-chains, may be present and make the
Figure 2. CE separation with UV absorption detection of the Hb digests for (a) HbA, (b) HbS, (c) HbE.
Conditions: VCE = –17 000 V, Capillary: APS coated, 60 cm, 40 µm i.d., 105 µm o.d. Buffer: 10 mM ammonium
acetate, pH = 4.0.
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resulting data particularly difficult to interpret for
unknowns. In the case of the total digest separated by
CE there may be as many as 10 peaks within a 1 min
period and it would be difficult to distinguish abnormal
from normal Hb using only total ion-electrophoro-
grams in cases where only small variations in structure
Figure 3. The TIE of the CE/MS of Hb digests for (a) HbA, (b) HbS, (c) HbE. Conditions: VCE = –13 000 V, VESI
= 4 000 V. Other conditions are the same as those in Fig. 2.
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Table 1. Comparison of the observed and calculated values of m/z fortryptic digests of the Hb â chain in CE/MS
Peptide Sequence m/z m/z Accuracy Migration time
Calculated Observed (min)
âT1 Val-His-Leu-Thr-Pro-Glua-Glu-Lys 952.1 952.4 0.03% 4.05
âT2 Ser-Ala-Val-Thr-Ala-Leu-Trp-Gly-Lys 932.1 932.3 0.02% 4.23
âT3 Val-Asn-Val-Asp-Glu-Val-Gly-Gly-Glub-Ala-Leu-Gly-Arg 1314.4 1314.1 –0.02% 4.36
âT4 Leu-Leu-Val-Val-Tyr-Pro-Trp-Thr-Gln-Arg 1274.5 1274.4 –0.01% 4.46
âT5 Phe-Phe-Glu-Ser-Phe-Gly-Asp-Leu-Ser-Thr-Pro-Asp-Ala-Val- 2059.3 2059.5 0.01% 4.67
Met-Gly-Asn-Pro-Lys
âT6 Val-Lys 245.3 not detected
âT7 Ala-His-Gly-Lys 411.5 not detected
âT9 Val-Leu-Gly-Ala-Phe-Ser-Asp-Gly-Leu-Ala-His-Leu-Asp- 1669.9 not detected
Asn-Leu-Lys
âT10+11 Leu-His-Val-Asp-Pro-Glu-Asn-Phe-Arg-Leu-His-Val-Asp- 2547.8 2546.4 –0.05% 4.78
Pro-Glu-Asn-Phe-Arg
âT13 Glu-Phe-Thr-Pro-Pro-Val-Gln-Ala-Ala-Tyr-Gln-Lys 1378.5 1378.2 –0.02% 4.95
âT14 Val-Val-Ala-Gly-Val-Ala-Asn-Ala-Leu-Ala-His-Lys 1149.4 1149.5 0.01% 5.03
âT15 Tyr-His 318.3 not detected
Calculated m/z values:
a HbS: The substitution of glutamate in HbA by valine causes the resulting fragment to be found at m/z 922.1, with a migration time at 4.98
min.
b HbE: The substitution of glutamate by lysine in this peptide results in an additional cleavage point under tryptic digestion. The resulting two
fragments have m/z values of 916.0 (âT18–26, eluting at 5.04 min.) and 415.5 (âT27–30, eluting at 4.47 min.), where the total of the two digest
products is 1331.5.
were involved. Although a mass spectrometer detector
can detect these small differences, interpretation will be
complicated by co-eluting peaks and other unseparated
background contaminants.
Figure 1 shows the separation of the α- and â-chains
of Hb using HPLC with a C18 column (30 cm × 4.6 mm)
and gradient elution (45–55% acetonitrile in 60 min).
The α-chain is observed at 30.63 min. and the â-chain at
26.82 min. A number of minor peaks, which are also
observed in the chromatogram, were not identified but
could result in background in our experiment if not
separated out using HPLC. This separation was per-
formed with ~ 10 µg of initial sample. A C18 column
was used in the HPLC separation as opposed to the C4
column used in earlier work by Shelton.6 It was found
that the use of C18 resulted in some sample loss, but
that the C4 column applied in these experiments did not
provide a satisfactory separation. The eluent was
fraction collected following separation and the mass
confirmed by MALDI-MS. The â-chains for various
Hbs were determined as âA (normal Hb), m/z 15 867;
âS (sickle-cell anemia), m/z 15 837; and âE, m/z 15 866,
respectively. In addition, the collected fractions of the
small background peaks were also subjected to mass
analysis so that their presence in the â-fraction could be
monitored.
Following separation of the globin chains of Hb by
HPLC, the fraction was dried and subjected to trypsin
digestion. The â-chain digests were then separated by
CE and initially detected by UV absorption detection.
In Fig. 2 is shown the CE electrophorograms of the
tryptic digests of the â-chains of three forms of Hb. In
Fig. 2(a) is shown the electrophorogram of normal
hemoglobin as the standard and in Fig. 2(b) and (c) are
shown the electrophorograms of the â-chains of HbS
and HbE respectively. Although the electrophorograms
are similar, there are clearly differences in the profiles.
Peaks that are different from the HbA standard and
suspected of containing a mutation site are marked by
an arrow. The variation in the Hbs may only be a single
amino acid, as in these cases, where the chain variations
in HbS and HbE are â6 (Glu→Val) and â26 (Glu→Lys),
respectively. Nevertheless, the use of CE can success-
fully separate and discriminate between the small
changes in digest peaks. In these cases such separation
may be due to the change in charge distribution, since
glutamate is negatively charged while valine is basically
neutral and lysine is positively charged at neutral pH.
The sharp separations demonstrate that the coating on
the capillary inner surface provides a positive layer that
repels the peptide successfully under the acidic condi-
tions. The separation generally was on the order of
1.5 × 104 theoretical plates in these experiments. The
optimum separation varied depending on the buffer pH
and the concentration of the samples and the migration
times also varied somewhat according to the conditions.
Nevertheless, relatively similar electrophorograms can
be observed for the different Hb variants as expected.
In comparison, in Fig. 3 is shown the total-ion
electrophorogram of Hb digest obtained using on-line
CE/MS. Most of the peaks observed correspond to the
CE separation with UV absorption detection of Fig. 2.
There are some differences in terms of peak width and
migration times. The differences in migration times
observed in CE/MS versus UV absorption detection
were due to the UV detector window being situated
6 cm before the capillary anode. The slightly broader
peak width in the TIE can be explained, according to
McLafferty and coworkers,32 by the fact that when the
capillary tip was exposed to atmosphere during electro-
spray, the solvent was easily evaporated due to the
small needle dimension. This evaporative effect at the
capillary tip subsequently induces a flow inside the
capillary. Furthermore, it was demonstrated by Mann,33
and later by McLafferty,32 that the electrostatic drawing
of the buffer solution and sample by the electric field
between the needle and the transit stainless steel
capillary results in a constant flow in the direction of
electrospray, even without the addition of the CE
voltage. Nevertheless, it is noteworthy that more than
10 peaks in the electrophorogram were separated in
1–2 min and the entire separation was completed in less
than 6 min where many of the peaks are as narrow as
1–2 s. The TIEs of Fig. 3 illustrate the capability of the
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IT/reTOF to acquire spectra for even the fastest
separation. The non-scanning characteristics of the IT/
reTOF, allows data acquisition at a rate of 0.04
s/spectrum, limited ultimately by the data system. In
these experiments, a 0.25 s data acquisition time was
used in order to compromise between preserving the
CE resolution and the mass sensitivity. In Table 1 is
listed a comparison of the calculated and observed
mass values of the tryptic digests of HbA in the CE/MS
experiment.
In Fig. 4 are shown the mass spectra corresponding to
the T1 digest products of HbA and HbS. As reported in
Shackleton’s17 earlier experiments in the LC/MS of
hemoglobin digests, the major ESI-produced ions of the
Hb protein digests were doubly-charged. Such doubly-
charged ions are indeed observed as shown in Fig. 4 and
can be confirmed as being doubly-charged using the
resolution of the IT/reTOF where the relative separa-
tion of the isotopic peaks in the doubly-charged ions is
half that of the singly-charged ions, as expected. We
examined the mass spectra of the particular TIE peaks
that appear to shift between the analysis of HbA and
HbS. This mutation site was substantiated by the mass
spectra where a mass shift of m/z 15 was observed for
Figure 4. Mass spectra of the âT1 fragment in HbA and HbS obtained in CE/MS experiment (a) HbA
âT1 fragment, (b) HbS variant âT1 fragment ion. Single mass spectrum acquisition time: 0.25 s,
VFocusing Lens = 100 V.
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doubly-charged ions. This corresponds to a mass shift of
30, which is expected for the substitution of glutamate
by a valine. The mass resolution in these experiments is
~ 2000 and the mass error is less than 0.05% as shown
in Table 1. Thus, it appears that this method clearly
demonstrates the expected mutation site and identity of
this sample as sickle cell anemia.
In the HbE electrophorogram with UV detection
and in the TIE of Figs 2 and 3, there were several
additional digest peaks observed compared to the case
of HbS and HbA. Since the glutamate is substituted by
a lysine in the HbE, it would be expected that trypsin
would cut the protein in this position resulting in two
additional fragments. In a comparison of the mass
spectral data of the CE separation of the tryptic digests
of HbA and HbE, two extra peaks at m/z 916 and m/z
Figure 5. Mass spectra of the âT3 fragment in HbA and corresponding fragments in HbE obtained in
CE/MS experiment where (a) corresponds to HbA âT3 fragment ion, (b) to HbE âT27–30 fragment,
and (c) to HbE âT18–26 fragment. These two fragment ions result from the tryptic digestion at the lysine
residue at â26 position in HbE.
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415.5 were observed in HbE â-chain, which correspond
to the â18–26 and â27–30 fragments, respectively. The
sum of these two fragments is equal to 1331.5, which is
the mass value of the âT3 peptide plus a water
molecule if this lysine position was not cleaved by
trypsin. The mass spectra for these fragments are shown
in Fig. 5.
In order to pinpoint the mutation site detected in
these specific fragments, collision-induced dissociation
was performed for the HbS âT1 fragment in the region
between the focusing lens and skimmer. Although this
method can not isolate the parent ion for fragmenta-
tion, the CE separation provided a preselection for the
specific ions. Shackleton et al. previously recorded CID
data from Hb variants by changing the nozzle-to-
skimmer voltage and inducing considerable fragmenta-
tion in the parent ion.18 In the present experiment,
when the âT1 was about to elute from the capillary in
the second run, immediately following the initial CE/
MS experiment, the focusing-lens voltage was raised
from 100 V to between 150 V and 200 V. In Fig. 6 (b) is
shown the HbS âT1 fragment CID spectrum. This was
obtained using a storage time of 0.5 s and signal
averaging the spectrum at least eight times. Thus, a total
effective time of 4 s was used to examine the CID
spectrum. An increase in storage time was needed to
enhance the signal-to-noise ratio in these experiments.
In the spectrum, the dominating fragment ions are of
the y- and b- series. The y3 and y6
2+ ions are 30 mass
units less than those in the HbA (see Fig. 6 (a)), as a
result of the substitution of the glutamic acid by valine
(Val-His-Leu-Thr-Pro-Val-Glu-Lys vs. Val-His-Leu-
Thr-Pro-Glu-Glu-Lys) whereas the y1, y2, and b2 ions
are the same as those in HbA, as expected. From these
data, it is quite clear that the â6 position is where the
substitution occurs.
CONCLUSION
CE/ESI using an IT/reTOF mass detector has been
used to provide a rapid and sensitive method for
analyzing structural variants in hemoglobin. Tryptic
digests of variant Hbs have been analyzed by this
method in which a comparison of the TIEs and mass
spectra of the mutant and normal Hbs can detect the
presence of the mutation site. In addition, CID in the
vacuum interface – skimmer region has been used to
pinpoint the identity of such a site in HbS, following
Figure 6. CID spectra of the âT1 fragment in (a) HbA and (b) HbS during the CE/MS experiment.
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separation of the peptide digest fraction by CE. The
CE/ESI-IT/reTOF/MS method is shown to have unique
capability for efficiently and accurately detecting fast
separations with narrow peaks that may be under 1 s
FWHM. The speed of this system is critical for the
isolation of the large number of peaks that must be
separated in a short time duration in these CE
experiments.
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